Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 5, 2024
Ethnicity and deprivation negatively impact the access to disease-modifying therapy for relapsing-remitting multiple sclerosis: a retrospective, single-centre study
Joyutpal Das, Gagana Mallawaarachchi, Jack Grimshaw, et al.
Practical Neurology
|
February 22, 2023
Outpatient neurology diagnostic coding: a proposed scheme for standardised implementation
Fran Biggin, Jo Knight, Rejith Dayanandan, et al.
Multiple Sclerosis and Related Disorders
|
January 6, 2024
Quantifying the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis in the United Kingdom: A time and motion study
David Rog, Wallace Brownlee, Francisco Javier Carod-Artal, et al.
Practical Neurology
|
July 8, 2022
Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines
Ruth Dobson, David Rog, Caroline Ovadia, et al.
Multiple Sclerosis and Related Disorders
|
May 7, 2024
Prevalence, treatment and correlates of depression in multiple sclerosis
Carolyn A Young, Dawn Langdon, David Rog, et al.
Journal of the Neurological Sciences
|
May 15, 2021
Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy
Carolyn A Young, Roger Mills, David Rog, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 19, 2025
Impact of relative deprivation and ethnicity on the incidence rate of amyotrophic lateral sclerosis
James Alder, Chukwu Chukwuma, Tracey Farragher, et al.
Journal of the Neurological Sciences
|
February 17, 2025
Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectories
Carolyn A Young, David Rog, Basil Sharrack, et al.
Multiple Sclerosis and Related Disorders
|
May 19, 2021
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
Afagh Garjani, Rodden M Middleton, Rachael Hunter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 6, 2023
Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus
Priyanka Iyer, Kate Wiles, Azza Ismail, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 5, 2024
Ethnicity and deprivation negatively impact the access to disease-modifying therapy for relapsing-remitting multiple sclerosis: a retrospective, single-centre study
Joyutpal Das, Gagana Mallawaarachchi, Jack Grimshaw, et al.
Practical Neurology
|
February 22, 2023
Outpatient neurology diagnostic coding: a proposed scheme for standardised implementation
Fran Biggin, Jo Knight, Rejith Dayanandan, et al.
Multiple Sclerosis and Related Disorders
|
January 6, 2024
Quantifying the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis in the United Kingdom: A time and motion study
David Rog, Wallace Brownlee, Francisco Javier Carod-Artal, et al.
Practical Neurology
|
July 8, 2022
Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines
Ruth Dobson, David Rog, Caroline Ovadia, et al.
Multiple Sclerosis and Related Disorders
|
May 7, 2024
Prevalence, treatment and correlates of depression in multiple sclerosis
Carolyn A Young, Dawn Langdon, David Rog, et al.
Journal of the Neurological Sciences
|
May 15, 2021
Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy
Carolyn A Young, Roger Mills, David Rog, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 19, 2025
Impact of relative deprivation and ethnicity on the incidence rate of amyotrophic lateral sclerosis
James Alder, Chukwu Chukwuma, Tracey Farragher, et al.
Journal of the Neurological Sciences
|
February 17, 2025
Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectories
Carolyn A Young, David Rog, Basil Sharrack, et al.
Multiple Sclerosis and Related Disorders
|
May 19, 2021
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
Afagh Garjani, Rodden M Middleton, Rachael Hunter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 6, 2023
Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus
Priyanka Iyer, Kate Wiles, Azza Ismail, et al.
Page
of 5